Middle East & Africa Immunodiagnostics Market 2022 Key Players, Top Regions, Growth, Size, Shares, Revenue Segmentations by Types, Applications

The MEA immunodiagnostics market is expected to grow from US$ 591.94 million in 2022 to US$ 927.14 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2022 to 2028.


Suryakant Gadekar

7 days ago | 6 min read

The current trend in immunodiagnostics is microfluidics and magnetic beads with potential commercialization. These sensitive, specific, and time-saving methodologies are essential in understanding and diagnosing various health conditions, including infectious diseases, metabolic disorders, and cardiac problems. The increasing applications of immunodiagnostic solutions encouraged the development of targeted treatments and therapies for precision health. The prominent market players are also propelling the assay technology and adopting microfluidics and magnetic beads. For immunoassays, magnetic particles such as Sera-Mag beads offer a convenient alternative to plate-based ELISAs, as both rely on the same assay principle. Merck KGaA launched the Magna Chip Protein A magnetic beads. This recombinant Protein A is covalently bound to magnetic beads for chromatin immunoprecipitations (Chip assays) and provides users with a rapid, reproducible, and efficient reagent for collecting immunocomplexes than agarose beads.

Get Exclusive Sample Pages of Middle East & Africa Immunodiagnostics Market @:

Kay Players:

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; Svar Life Science AB; and Thermo Fisher Scientific Inc are the leading companies operating in the MEA immunodiagnostics market.

The MEA immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the MEA immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassay (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment registered the largest market share in 2022.

Based on clinical indication, the MEA immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics and others. The infectious diseases segment registered the largest market share in 2022.

Based on end user, the MEA immunodiagnostics market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospital segment registered the largest market share in 2022.

Based on country, the MEA immunodiagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Saudi Arabia dominated the market in 2022.

In microfluidics, some immunodiagnostics target single biomarkers. However, a recent trend shows that a multiple analyte detection system is required according to the complexity of the disease and the need to make early reliable diagnoses. OPKO Health's test uses microfluidics, a recent development in immunodiagnostics, to assay an array of biomarkers. On September 15, 2022, Siemens Healthineers released its new CE-marked SARS-CoV-2/FluA/FluB/HRSV assay, a PCR test, and the CLINITEST Rapid COVID-19 + Influenza Antigen Test. The new FTD SARS-CoV-2/FluA/FluB/HRSV assay enables comprehensive and semi-automated molecular testing for seasonal respiratory pathogens. The combination PCR test detects and differentiates clinically relevant viruses such as SARS-CoV-2, Influenza A, Influenza B, and HRSV A/B. This research report provides insights into the “Middle East & Africa Immunodiagnostics Market.” This report summarizes the results of the assessment carried out by Business Market Insights in the field of the Benefits Management Platform for the global perspective. The report provides an analysis of the Benefits Middle East & Africa Immunodiagnostics Market by deployment, application, and geography.

Research and development (R&D) has been the crucial part of the pharmaceutical business. It enables companies to develop new products with significant medical and commercial potential for various diagnostic applications. Due to the surging prevalence of infectious diseases, companies are investing and generating huge revenues for expansion activities. During the COVID-19 pandemic, Thermo Fisher Scientific Inc. witnessed a 48% increase in the sales of its specialty diagnostics segment (sub-segmented into clinical diagnostics, immunodiagnostics, microbiology, transplant diagnostics, and healthcare market channel) in 2020. The segmental revenue of the company further increased in 2021 due to higher demand and sales of immunodiagnostic products used in the treatment of COVID-19. Manufacturers have also made some key investments in the last few years. Cisco Systems, a global technology leader, invested US$ 225 million to combat the COVID-19 pandemic. This enabled the company to expand significantly and also encourage new players to enter the MEA immunodiagnostics market.

Get Full Report:

The report provides the current market size for the Middle East & Africa Immunodiagnostics Market, defines trends, and presents growth forecasts for nine years from 2022 to 2028. 2022 is considered as the base year, and 2022 to 2028 is the forecast year for the entire report. All the market numbers for revenue are provided in US dollars. The market is analyzed by the supply side, considering the market penetration of Benefits Management Platform for all the regions globally.

This research report on the “Middle East & Africa Immunodiagnostics Market” provides a holistic view of the global market size across major regions. The report further elucidates the key driving factors, restraints, growth opportunities, and future trends about the market growth. The market is segmented into deployment, application, and geography.

Market Drivers

Market Restraints

Future Trends

Market Opportunities

Middle East & Africa Immunodiagnostics Market Research Report Scenario includes:

The report provides qualitative and quantitative trends of the global Middle East & Africa Immunodiagnostics Market.

The report provides qualitative and quantitative trends of the global Middle East & Africa Immunodiagnostics Market segmented by deployment, component, solution, application, and geography.

Buy a copy of this Middle East & Africa Immunodiagnostics Market research report at @:

The report starts with the key takeaways, highlighting the key trends and outlook of the global Middle East & Africa Immunodiagnostics Market.

Chapter 3 provides the research methodology of the study.

Chapter 4 provides a brief overview of the Benefits Middle East & Africa Immunodiagnostics Market landscape. It further provides the segmentation of the market with PEST analysis on global scenarios along with ecosystem analysis and expert opinions.

Chapter 5 highlights the Benefits Middle East & Africa Immunodiagnostics Market trends and outlook and the prevailing factors that are driving the market, as well as are deterrents to market growth, along with their impact analysis.

Chapter 6 discusses the market revenue and forecast, in the global Middle East & Africa Immunodiagnostics Market.

Chapter 7, 8, and 9 discuss the market segmented by deployment, application, and geography across the regions.

Chapter 10 provides the impact of COVID 19 across the regions and respective countries.

Chapter 11 provides the industry landscape and highlights the major market events, as well as major market vendors in the ecosystem.

Chapter 12 provides the detailed profiles of the key companies operating within the Benefits Middle East & Africa Immunodiagnostics Market. The companies have been profiled based on their key facts, business descriptions, financial overview, SWOT analysis, and key developments.

Chapter 13, i.e., the appendix is inclusive of a brief overview of the company, glossary of terms, contact information, and the disclaimer section.

The report also covers a detailed chapter of the analysis on COVID-19 impact on this market at the global and regional level in our final reports.

This research provides detailed information regarding the major factors influencing the growth of the Middle East & Africa Immunodiagnostics Market at the Regional Level (drivers, restraints, opportunities, and challenges), forecast of the market size, in terms of value, market share by region and segment; regional market positions; segment and country opportunities for growth; New product developments, strengths, and weaknesses, brand portfolio; Marketing and distribution strategies; challenges and threats from current competition and prospects; Key company profiles, SWOT, product portfolio and growth strategies.

Primary Research:

“Business Market Insights” conducts hundreds of primary interviews a year with industry participants and commentators to validate its data and analysis. A typical research interview fulfills the following functions:

Provides First-Hand Information on the Market Size, Market Trends, Growth Trends, Competitive Landscape, and Future Outlook

Validates and Strengthens Secondary Research Findings

Further Develops the Analysis Team’s Expertise and Market Understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry Participants: VPs, Business Development Managers, Market Intelligence Managers and National Sales Managers

Outside Experts: Valuation Experts, Research Analysts and Key Opinion Leaders Specializing in the Industry

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact Us:

If you have any queries about this report or if you would like further information, please

Contact Person: Sameer Joshi

Phone: +442081254005

E-Mail ID:

Web URL:

Blog URL:


Created by

Suryakant Gadekar







Related Articles